Adrian Hayday

29PUBLICATIONS
311CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Feb 11, 2026
Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy.

Bruno Silva-Santos, Sofia Mensurado, Rafael Blanco-Domínguez

|Nov 18, 2025
Guidelines for T cell nomenclature.

David Masopust, Amit Awasthi, Rémy Bosselut

|Nov 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).

Evangelos Bellos, Dilys Santillo, Pierre Vantourout

|Oct 03, 2024
Cancer immunotherapy by γδ T cells.

Adrian Hayday, Julie Dechanet-Merville, Jamie Rossjohn

|Jan 03, 2024
PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy.

Daniel Davies, Shraddha Kamdar, Richard Woolf

|Dec 06, 2023
Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials.

Pierre Vantourout, Josephine Eum, María Conde Poole

Pageof 5

Frequent Collaborators

12 joint publications

Pierre Vantourout

7 joint publications

Yin Wu

6 joint publications

Leticia Monin

6 joint publications

Blair Merrick